27th National Clinical Education Symposium Presentation Abstracts

Actions for Presentation

Download PDF Back to list

Other presentations

The Role of Low Anxiety Scores on Novelty Responses in Preclinical Alzheimer’s Groups - Page S89
Ugur Cikrikcili, Thomas Nickl Jockschat, Björn Schott, Ulaş Ay, René Lattmann5, David Berron, Emrah Duzel

The Relationship Between Attachment Style and Aggression and Addiction Severity in People with Substance Use Disorders - Page S90
Feyza Dönmez, Merve Akkuş, Kader Semra Karataş, Onur Gökçen

Investigation of Stress, Anxiety and Coping Strategies in Patients with Vertigo - Page S91
Mehmet Akif Dündar, Fatmanur Akgün Kılavuz, Hasan Bakay, Mehmet Ak

Impulsivity and Reward-Related Eating in Obesity: Is Premeditation a Determining Factor? - Page S92
Furkan Çınar, Ömer Bayırlı, Zehra Eratıcı, Memduha Aydin

Comparison of Carotid Media Intima Thickness and Ankle-Brachial Pressure Index in Patients Diagnosed with Schizophrenia or Bipolar Disorder with Healthy Controls - Page S93
Esra Göçer, Atilla Tekin

Eating Behaviors, Orthorexia, Self-Esteem, and Life Satisfaction in Individuals with Celiac Disease - Page S94
Ümmü Nur Kaya Tan, Büşra Başer Özkoç, Ali Erdoğan, Sercan Karabulut, Buket Cinemre, Burak Kulaksızoğlu

29 APRIL 2025, TUESDAY
11:45-13:00 ORAL PRESENTATION SESSION - 6

Somatic comorbidities in adults with ADHD: Prevalence and clinical associations

Elif Yıldız1, Ali Kandeger1

1. Department of Psychiatry, Selçuk University, Konya, Turkey

DOI: 10.5080/kes27.abs64 Page 88

BACKGROUND AND AIM:Attention-Deficit/Hyperactivity Disorder (ADHD) is a common neuropsychiatric disorder that persists from childhood into adulthood. While psychiatric comorbidities in ADHD present major clinical and public health challenges, somatic comorbidities are also prevalent but less studied. These may stem from shared etiological mechanisms or ADHD-related lifestyle factors. The limited research on somatic conditions in ADHD creates a gap in diagnosis and treatment, despite evidence linking ADHD to early mortality and reduced life expectancy. This study aims to assess the prevalence of somatic comorbidities in adults with ADHD and their associations with clinical characteristics.
METHODS (Ethics Committee Approval must be obtained and the number should be specified.):We retrospectively reviewed medical records of 358 adults diagnosed with ADHD at the Adult Neurodevelopmental Disorders Clinic, Department of Psychiatry, Selçuk University. Demographic and clinical data were extracted and statistically analyzed. The study was approved by the Selçuk University Ethics Committee (Decision No: 2024/425).
RESULTS:Of the patients, 51.1% were female and 48.9% male, with a mean age of 23.7 ± 6.01 years (range: 16–49). ADHD was diagnosed before age 18 in 29.7% and in adulthood in 70.3%, with a mean diagnosis age of 20.7 ± 8.07 years. Somatic comorbidities were present in 22.3%, most commonly obesity (10.3%) and asthma, followed by allergies, migraines, celiac disease, and thyroid disorders. Cardiac, metabolic, and allergic/autoimmune conditions were found in 3.4%, 5.3%, and 8.7% of cases, respectively. Somatic comorbidities were significantly more frequent in females and in those diagnosed at a younger age.
CONCLUSIONS:This study underscores the strong link between ADHD and somatic comorbidities, highlighting the need for an integrated clinical approach. Obesity and asthma were most common, likely influenced by shared etiology, ADHD-related lifestyle factors, or high comorbidity rates. Somatic conditions may affect treatment decisions, requiring careful monitoring of stimulant use. Routine screening in both directions could improve clinical outcomes.